The global HIV antivirals market is expected to be worth US$ 30.6 billion in 2022. The HIV antivirals market is expected to reach US$ 47.0 Billion by the end of 2032, with sales revenue expected to register a 4.4% CAGR over the forecast period (2022 to 2032). According to a recent estimate, fixed-dose combos (FDCs) …